お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
977665

獣医用分子診断の世界市場の分析:家畜・ペットの人獣共通感染症の有病率上昇による成長促進

Global Market Study on Veterinary Molecular Diagnostics: Increasing Prevalence of Zoonotic Diseases among Livestock & Companion Animals to Spur Growth

出版日: | 発行: Persistence Market Research | ページ情報: 英文 269 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.49円
獣医用分子診断の世界市場の分析:家畜・ペットの人獣共通感染症の有病率上昇による成長促進
出版日: 2020年11月17日
発行: Persistence Market Research
ページ情報: 英文 269 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の獣医向け・動物用の分子診断の市場について分析し、技術の概要や市場の構造、主な市場促進・抑制要因、市場規模・シェアの推移と予測 (2020年~2030年)、製品種類別・疾患の種類別・動物の種類別・エンドユーザー別および地域別・主要国の詳細動向、現在の市場競争状態、主要企業のプロファイルなどを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 市場概略

第3章 主な市場動向

  • 市場を左右する主な動向
  • 製品イノベーション/開発の動向

第4章 主な成功要因

  • 製品の普及状況
  • 主要規制
  • 主要企業:競争マッピング

第5章 市場の背景事情

  • マクロ経済的要因
    • 新興国の都市化と生活水準の上昇
    • 肥満率の増加に伴う、正確な分子診断に対する需要の拡大
    • ペットの健康に対する関心の増大
  • 予測要因:関連性と影響度
    • 世界各国での動物の病気に対する関心の増大
    • 獣医用の分子診断キットの普及
    • 動物の慢性疾患/感染症の有病率の上昇
    • 主要企業間の戦略的協力の増加
    • 分子技術の進歩
    • 高度な分子診断技術の浸透
    • FDAの認証基準の緩和
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会の分析
  • 新型コロナウイルス感染症 (COVID-19) 危機の分析
    • COVID-19:現在の統計データと将来の予想
    • 現在のGDP予測と予想される影響
    • 現時点での経済予測:2008年の経済分析との比較
    • COVID-19と影響分析
    • 2020年の市場シナリオ
    • 四半期ごとの予測
    • 回復シナリオの予測 (四半期ベース)
    • 回復シナリオ:短期的・中期的・長期的影響

第6章 世界の獣医用分子診断市場の分析と予測

  • 過去の市場と分析
  • 現在・将来の市場と予測
    • 対前年比成長率 (YoY) の動向分析

第7章 世界の獣医用分子診断市場の分析と予測:製品種類別

  • イントロダクション/主な調査結果
  • 過去の市場規模の分析:製品種類別 (数量ベース)
  • 現在・将来の市場規模の分析と予測:製品種類別
    • PCRキット
    • INAATキット
    • マイクロアレイキット
    • DNAシーケンシングキット
  • 市場求心力分析:製品種類別

第8章 世界の獣医用分子診断市場の分析と予測:疾患の種類別

  • イントロダクション/主な調査結果
  • 過去の市場規模の分析:疾患の種類別 (数量ベース)
  • 現在・将来の市場規模の分析と予測:疾患の種類別
    • アナプラズマ属
    • エールリヒア属
    • ニューキャッスル病
    • インフルエンザ
    • 豚繁殖・呼吸障害症候群(PRRS)
    • その他
  • 市場求心力分析:疾患の種類別

第9章 世界の獣医用分子診断市場の分析と予測:動物の種類別

  • イントロダクション/主な調査結果
  • 過去の市場規模の分析:動物の種類別 (数量ベース)
  • 現在・将来の市場規模の分析と予測:動物の種類別
    • 家畜
    • ペット (コンパニオンアニマル)
  • 市場求心力分析:動物の種類別

第10章 世界の獣医分子診断市場の分析と予測:エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模の分析:エンドユーザー別 (数量ベース)
  • 現在・将来の市場規模の分析と予測:エンドユーザー別
    • 動物病院
    • 臨床検査室
    • 獣医学研究所
  • 市場求心力分析:エンドユーザー別

第11章 世界の獣医用分子診断市場の分析と予測:地域別

  • イントロダクション
  • 過去の市場規模の分析:地域別
  • 現在・将来の市場規模の分析と予測:地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ(MEA)
  • 市場求心力分析:地域別

第12章 北米の獣医用分子診断市場の分析と予測

  • イントロダクション
  • 過去の市場規模の分析:市場区分別
  • 市場規模の予測:市場区分別 (金額・数量ベース)
    • 国別
    • 製品種類別
    • 疾患の種類別
    • 動物の種類別
    • 流通チャネル別
  • 市場求心力分析
  • 主な市場参入企業:競争密度マッピング
  • 市場促進・抑制要因:影響度の分析

第13章 ラテンアメリカの獣医用分子診断市場の分析と予測

第14章 欧州の獣医用分子診断市場の分析と予測

第15章 南アジアの獣医用分子診断市場の分析と予測

第16章 東アジアの獣医用分子診断市場の分析と予測

第17章 オセアニアの獣医用分子診断市場の分析と予測

第18章 中東・アフリカの獣医用分子診断市場の分析と予測

第19章 主要国・新興国の獣医用分子診断市場の分析と予測

  • イントロダクション
    • 市場価値・シェア分析:主要国別
    • 市場成長率の比較:世界全体/各国レベル
  • 米国分析
    • 製品種類別
    • 病気の種類別
    • 動物の種類別
    • エンドユーザー別
  • カナダ市場
  • メキシコ市場
  • ブラジル市場
  • 英国市場
  • ドイツ市場
  • フランス市場
  • イタリア市場
  • スペイン市場
  • ベネルクス諸国市場
  • ロシア市場
  • 中国市場
  • 日本市場
  • 韓国市場
  • インド市場
  • 東南アジア市場
  • オーストラリア市場
  • ニュージーランド市場
  • 湾岸協力会議 (GCC) 諸国市場
  • トルコ市場
  • 南アフリカ市場

第20章 競合分析

  • 競争ダッシュボード
  • 企業間の比較分析
  • 競争の詳細
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Qiagen N.V.
    • Neogen Corporation
    • ID.Vet
    • INDICAL BIOSCIENCE GmbH
    • Veterinary Molecular Diagnostics, Inc.

第21章 前提条件、頭字語の一覧

第22章 調査方法

図表

List of Tables

  • Table 01: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 02: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 03: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species
  • Table 04: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2017 and Forecast 2020-2030, By End User
  • Table 05: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013-2017 and Forecast 2020-2030, By Region
  • Table 06: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 07: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product
  • Table 08: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 09: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species
  • Table 10: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 11: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 12: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 13: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 14: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species type
  • Table 15: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 16: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 17: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 18: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 19: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 20: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 21: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 23: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 24: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 25: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 26: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 27: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 28: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 29: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 30: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 31: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 32: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 33: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 34: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 35: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User
  • Table 36: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 37: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 38: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Disease Type
  • Table 39: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Species Type
  • Table 40: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By End User

List of Figures

  • Figure 01: Global Veterinary Molecular Diagnostics Market Value Analysis and Forecast, 2020-2030 (US$ Mn)
  • Figure 02: Global Veterinary Molecular Diagnostics Market Absolute $ Opportunity (US$ Mn), 2020-2030
  • Figure 03: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Product Type, 2020 & 2030
  • Figure 04: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Product Type, 2020-2030
  • Figure 05: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Product Type, 2020-2030
  • Figure 06: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Disease Type, 2020 & 2030
  • Figure 07: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Disease Type, 2020-2030
  • Figure 08: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Disease Type, 2020-2030
  • Figure 09: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Species, 2020 & 2030
  • Figure 10: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Species, 2020-2030
  • Figure 11: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Species, 2020-2030
  • Figure 12: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By End User, 2020 & 2030
  • Figure 13: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By End User, 2020-2030
  • Figure 14: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By End User, 2020-2030
  • Figure 15: Global Veterinary Molecular Diagnostics Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 16: Global Veterinary Molecular Diagnostics Market Y-o-Y Growth (%) By Region, 2020-2030
  • Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis By Region, 2020-2030
  • Figure 18: North America Veterinary Molecular Diagnostics Market Value Share, By Product Type
  • Figure 19: North America Veterinary Molecular Diagnostics Market Value Share, By Disease Type
  • Figure 20: North America Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 21: North America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 22: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 23: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 24: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 25: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 26: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 28: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 29: Latin America Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 30: Latin America Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 31: Latin America Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 32: Latin America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 33: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 35: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 36: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 37: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 38: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 39: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 40: Europe Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 43: Europe America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 44: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 45: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 46: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 51: South Asia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 52: South Asia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 53: South Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 54: South Asia America Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 55: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 56: South Asia Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 57: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 58: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 59: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 60: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 61: South Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 62: East Asia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 63: East Asia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 64: East Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 65: East Asia Veterinary Molecular Diagnostics Market Value Share (2020E), By Country
  • Figure 66: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 67: East Asia Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 68: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 69: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 70: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 71: East Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 72: East Asia Asia Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 73: Oceania Veterinary Molecular Diagnostics Market Value Share, By Product Type (2019A)
  • Figure 74: Oceania Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2019A)
  • Figure 75: Oceania Veterinary Molecular Diagnostics Market Value Share (2019A), By Species & End User
  • Figure 76: Oceania Veterinary Molecular Diagnostics Market Value Share (2019A), By Country
  • Figure 77: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 78: Oceania Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 79: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 80: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 81: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 82: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 83: Oceania Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 84: MEA Veterinary Molecular Diagnostics Market Value Share, By Product Type (2019A)
  • Figure 85: MEA Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2019A)
  • Figure 86: MEA Veterinary Molecular Diagnostics Market Value Share (2019A), By Species & End User
  • Figure 87: MEA Veterinary Molecular Diagnostics Market Value Share (2019A), By Country
  • Figure 88: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis, 2015-2019
  • Figure 89: MEA Veterinary Molecular Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2020-2030
  • Figure 90: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Product Type
  • Figure 91: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type
  • Figure 92: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Species
  • Figure 93: MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By End User
  • Figure 94 MEA Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Country
  • Figure 95: U.S. Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 96: U.S. Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 97: U.S. Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 98: Canada Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 99: Canada Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 100: Canada Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 101: Brazil Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 102: Brazil Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 103: Brazil Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 104: Mexico Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 105: Mexico Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 105: Mexico Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 107: U.K. Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 108: U.K. Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 109: U.K. Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 110: Germany Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 111: Germany Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 112: Germany Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 113: France Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 114: France Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 115: France Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 116: Italy Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 117: Italy Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 118: Italy Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 119: Spain Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 120: Spain Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 121: Spain Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 122: Russia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 123: Russia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 124: Russia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 125: India Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 126: India Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 127: India Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 128: Thailand Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 129: Thailand Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 130: Thailand Veterinary Molecular Diagnostics Market Value Share (2020E) By Species & End User
  • Figure 131: Indonesia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 132: Indonesia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 133: Indonesia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 134: Malaysia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 135: Malaysia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 136: Malaysia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 137: China Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 138: China Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 139: China Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 140: Japan Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 141: Japan Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 142: Japan Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 143: South Korea Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 144: South Korea Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E))
  • Figure 145: South Korea Veterinary Molecular Diagnostics Market Value Share (2020E)), By Species & End User
  • Figure 146: Australia Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 147: Australia Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 148: Australia Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 149: New Zealand Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 150: New Zealand Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 151: New Zealand Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 152: GCC Countries Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 153: GCC Countries Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 154: GCC Countries Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
  • Figure 155: South Africa Veterinary Molecular Diagnostics Market Value Share, By Product Type (2020E)
  • Figure 156: South Africa Veterinary Molecular Diagnostics Market Value Share, By Disease Type (2020E)
  • Figure 157: South Africa Veterinary Molecular Diagnostics Market Value Share (2020E), By Species & End User
目次
Product Code: PMRREP12874

Scope of the Report:

A latest publication by Persistence Market Research (PMR) on the global veterinary molecular diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global veterinary molecular diagnostics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the veterinary molecular diagnostics market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.

Important indicators for the successful growth of the veterinary molecular diagnostics market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR. This research study can support readers to know the demand for veterinary molecular diagnostic products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the veterinary molecular diagnostics market, including market investors and service providers, and can help them in developing suitable business strategies to flourish in the veterinary molecular diagnostics market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the veterinary molecular diagnostics market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the veterinary molecular diagnostics market are also included in the current study. Depending on potential developments in the veterinary molecular diagnostics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the veterinary molecular diagnostics industry can be aided in making suitable company choices to achieve traction in the market space.

Key Segmentation:

PMR's study on the veterinary molecular diagnostics market offers information divided into five important segments-product, disease, species, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Product

  • PCR Kits
  • RT-PCR Kits
  • RAPD-PCR Kits
  • INAAT Kits
  • Microarray Kits
  • DNA Sequencing Kits

Disease

  • Anaplasma spp.
  • Ehrlichia spp.
  • New Castle Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

Species

  • Livestock Animals
    • Equine
    • Porcine
    • Poultry
    • Bovine/Cattle
    • Aquatic
    • Ovine
  • Companion Animals
    • Canine
    • Feline
    • Avian

End User

  • Veterinary Hospitals
  • Clinical Laboratories
  • Veterinary Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered:

  • Which regions will continue to remain the most profitable regional markets for veterinary molecular diagnostics?
  • Which factors will induce a change in the demand for veterinary molecular diagnostics during the assessment period?
  • How will COVID-19 change the trends in the veterinary molecular diagnostics market?
  • How can market players capture the low-hanging opportunities in the veterinary molecular diagnostics market in developed regions?
  • What are the winning strategies of stakeholders in the veterinary molecular diagnostics market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and tackle while investing in the veterinary molecular diagnostics market?
  • What are the developmental trends in veterinary molecular diagnostics sectors that will impact the market?
  • How can businesses in the veterinary molecular diagnostics market avail the growth opportunities in developed and emerging economies?

Research Methodology:

In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the veterinary molecular diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the veterinary molecular diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals using veterinary molecular diagnostics, and key executive of product manufacturing companies, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the veterinary molecular diagnostics market, and makes PMR's projections on the growth prospects of the veterinary molecular diagnostics market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Market Context

  • 4.1. Product Penetration
  • 4.2. Key Regulations
  • 4.3. Key Competition Mapping

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Increasing Urbanization and Growing Affluence in Emerging Countries
    • 5.1.2. Growing Demand for Precise Molecular Diagnosis Coupled with Increasing Obesity Rate
    • 5.1.3. Increasing Awareness Towards Pet Health
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rise in Awareness About Diseases in Animals Worldwide
    • 5.2.2. High Adoption of Molecular Diagnostic Kits for Veterinary Applications
    • 5.2.3. Higher Prevalence of Chronic & Infectious Diseases in Animals
    • 5.2.4. Increasing Strategic Collaborations Among Key Players
    • 5.2.5. Advancements in Molecular Technology
    • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
    • 5.2.7. Ease In FDA Clearance
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis
  • 5.4. COVID19 Crisis Analysis
    • 5.4.1. Current COVID19 Statistics and Probable Future Impact
    • 5.4.2. Current GDP Projection and Probable Impact
    • 5.4.3. Current Economic Projection as compared to 2008 Economic analysis
    • 5.4.4. COVID19 and Impact Analysis
      • 5.4.4.1. Revenue By Product Type
      • 5.4.4.2. Revenue By Disease Type
      • 5.4.4.3. Revenue By Species Type
      • 5.4.4.4. Revenue By End User
      • 5.4.4.5. Revenue By Country
    • 5.4.5. 2020 Market Scenario
    • 5.4.6. Quarter by Quarter Forecast
    • 5.4.7. Projected recovery Quarter
    • 5.4.8. Recovery Scenario - Short term, Midterm and Long Term Impact

6. Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
    • 7.3.1. PCR Kits
      • 7.3.1.1. RT-PCR Kits
      • 7.3.1.2. RAPD-PCR Kits
    • 7.3.2. INAAT Kits
    • 7.3.3. Microarray Kits
    • 7.3.4. DNA Sequencing Kits
  • 7.4. Market Attractiveness Analysis By Product Type

8. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Disease Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Disease Type, 2015-2019
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2020-2030
    • 8.3.1. Anaplasma spp.
    • 8.3.2. Ehrlichia spp.
    • 8.3.3. New Castle Disease
    • 8.3.4. Influenza
    • 8.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis By Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Species Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Species Type, 2015-2019
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Species Type, 2020-2030
    • 9.3.1. Livestock Animals
      • 9.3.1.1. Equine
      • 9.3.1.2. Porcine
      • 9.3.1.3. Poultry
      • 9.3.1.4. Bovine/Cattle
      • 9.3.1.5. Aquatic
      • 9.3.1.6. Ovine
    • 9.3.2. Companion Animals
      • 9.3.2.1. Canine
      • 9.3.2.2. Feline
      • 9.3.2.3. Avian
  • 9.4. Market Attractiveness Analysis By Species Type

10. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Clinical Laboratories
    • 10.3.3. Veterinary Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product Type
    • 12.3.3. By Disease Type
    • 12.3.4. By Species Type
    • 12.3.5. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Key Market Participants - Intensity Mapping
  • 12.6. Drivers and Restraints - Impact Analysis

13. Latin America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product Type
    • 13.3.3. By Disease Type
    • 13.3.4. By Species Type
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Key Market Participants - Intensity Mapping
  • 13.6. Drivers and Restraints - Impact Analysis

14. Europe Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product Type
    • 14.3.3. By Disease Type
    • 14.3.4. By Species Type
    • 14.3.5. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis

15. South Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Product Type
    • 15.3.3. By Disease Type
    • 15.3.4. By Species Type
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. East Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product Type
    • 16.3.3. By Disease Type
    • 16.3.4. By Species Type
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Oceania Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product Type
    • 17.3.3. By Disease Type
    • 17.3.4. By Species Type
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Product Type
    • 18.3.3. By Disease Type
    • 18.3.4. By Species Type
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. Veterinary Molecular Diagnostics Market Analysis
    • 19.2.1. By Product Type
    • 19.2.2. By Disease Type
    • 19.2.3. By Species Type
    • 19.2.4. By End User
  • 19.3. Canada Veterinary Molecular Diagnostics Market Analysis
    • 19.3.1. By Product Type
    • 19.3.2. By Disease Type
    • 19.3.3. By Species Type
    • 19.3.4. By End User
  • 19.4. Mexico Veterinary Molecular Diagnostics Market Analysis
    • 19.4.1. By Product Type
    • 19.4.2. By Disease Type
    • 19.4.3. By Species Type
    • 19.4.4. By End User
  • 19.5. Brazil Veterinary Molecular Diagnostics Market Analysis
    • 19.5.1. By Product Type
    • 19.5.2. By Disease Type
    • 19.5.3. By Species Type
    • 19.5.4. By End User
  • 19.6. U.K. Veterinary Molecular Diagnostics Market Analysis
    • 19.6.1. By Product Type
    • 19.6.2. By Disease Type
    • 19.6.3. By Species Type
    • 19.6.4. By End User
  • 19.7. Germany Veterinary Molecular Diagnostics Market Analysis
    • 19.7.1. By Product Type
    • 19.7.2. By Disease Type
    • 19.7.3. By Species Type
    • 19.7.4. By End User
  • 19.8. France Veterinary Molecular Diagnostics Market Analysis
    • 19.8.1. By Product Type
    • 19.8.2. By Disease Type
    • 19.8.3. By Species Type
    • 19.8.4. By End User
  • 19.9. Italy Veterinary Molecular Diagnostics Market Analysis
    • 19.9.1. By Product Type
    • 19.9.2. By Disease Type
    • 19.9.3. By Species Type
    • 19.9.4. By End User
  • 19.10. Spain Veterinary Molecular Diagnostics Market Analysis
    • 19.10.1. By Product Type
    • 19.10.2. By Disease Type
    • 19.10.3. By Species Type
    • 19.10.4. By End User
  • 19.11. BENELUX Veterinary Molecular Diagnostics Market Analysis
    • 19.11.1. By Product Type
    • 19.11.2. By Disease Type
    • 19.11.3. By Species Type
    • 19.11.4. By End User
  • 19.12. Russia Veterinary Molecular Diagnostics Market Analysis
    • 19.12.1. By Product Type
    • 19.12.2. By Disease Type
    • 19.12.3. By Species Type
    • 19.12.4. By End User
  • 19.13. China Veterinary Molecular Diagnostics Market Analysis
    • 19.13.1. By Product Type
    • 19.13.2. By Disease Type
    • 19.13.3. By Species Type
    • 19.13.4. By End User
  • 19.14. Japan Veterinary Molecular Diagnostics Market Analysis
    • 19.14.1. By Product Type
    • 19.14.2. By Disease Type
    • 19.14.3. By Species Type
    • 19.14.4. By End User
  • 19.15. South Korea Veterinary Molecular Diagnostics Market Analysis
    • 19.15.1. By Product Type
    • 19.15.2. By Disease Type
    • 19.15.3. By Species Type
    • 19.15.4. By End User
  • 19.16. India Veterinary Molecular Diagnostics Market Analysis
    • 19.16.1. By Product Type
    • 19.16.2. By Disease Type
    • 19.16.3. By Species Type
    • 19.16.4. By End User
  • 19.17. ASEAN Veterinary Molecular Diagnostics Market Analysis
    • 19.17.1. By Product Type
    • 19.17.2. By Disease Type
    • 19.17.3. By Species Type
    • 19.17.4. By End User
  • 19.18. Australia Veterinary Molecular Diagnostics Market Analysis
    • 19.18.1. By Product Type
    • 19.18.2. By Disease Type
    • 19.18.3. By Species Type
    • 19.18.4. By End User
  • 19.19. New Zealand Veterinary Molecular Diagnostics Market Analysis
    • 19.19.1. By Product Type
    • 19.19.2. By Disease Type
    • 19.19.3. By Species Type
    • 19.19.4. By End User
  • 19.20. GCC Countries Veterinary Molecular Diagnostics Market Analysis
    • 19.20.1. By Product Type
    • 19.20.2. By Disease Type
    • 19.20.3. By Species Type
    • 19.20.4. By End User
  • 19.21. Turkey Veterinary Molecular Diagnostics Market Analysis
    • 19.21.1. By Product Type
    • 19.21.2. By Disease Type
    • 19.21.3. By Species Type
    • 19.21.4. By End User
  • 19.22. South Africa Veterinary Molecular Diagnostics Market Analysis
    • 19.22.1. By Product Type
    • 19.22.2. By Disease Type
    • 19.22.3. By Species Type
    • 19.22.4. By End User

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
      • 20.3.1.1. bioMerieux SA
      • 20.3.1.2. Overview
      • 20.3.1.3. Product Portfolio
      • 20.3.1.4. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.1.5. Sales Footprint
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. IDEXX Laboratories, Inc.
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.2.4. Sales Footprint
      • 20.3.2.5. Strategy Overview
        • 20.3.2.5.1. Marketing Strategy
        • 20.3.2.5.2. Product Strategy
        • 20.3.2.5.3. Channel Strategy
    • 20.3.3. Thermo Fisher Scientific Inc.
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.3.4. Sales Footprint
      • 20.3.3.5. Strategy Overview
        • 20.3.3.5.1. Marketing Strategy
        • 20.3.3.5.2. Product Strategy
        • 20.3.3.5.3. Channel Strategy
    • 20.3.4. Qiagen N.V.
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.4.4. Sales Footprint
      • 20.3.4.5. Strategy Overview
        • 20.3.4.5.1. Marketing Strategy
        • 20.3.4.5.2. Product Strategy
        • 20.3.4.5.3. Channel Strategy
    • 20.3.5. Neogen Corporation
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.5.4. Sales Footprint
      • 20.3.5.5. Strategy Overview
        • 20.3.5.5.1. Marketing Strategy
        • 20.3.5.5.2. Product Strategy
        • 20.3.5.5.3. Channel Strategy
    • 20.3.6. ID.Vet
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.6.4. Sales Footprint
      • 20.3.6.5. Strategy Overview
        • 20.3.6.5.1. Marketing Strategy
        • 20.3.6.5.2. Product Strategy
        • 20.3.6.5.3. Channel Strategy
    • 20.3.7. INDICAL BIOSCIENCE GmbH
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.7.4. Sales Footprint
      • 20.3.7.5. Strategy Overview
        • 20.3.7.5.1. Marketing Strategy
        • 20.3.7.5.2. Product Strategy
        • 20.3.7.5.3. Channel Strategy
    • 20.3.8. Veterinary Molecular Diagnostics, Inc.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 20.3.8.4. Sales Footprint
      • 20.3.8.5. Strategy Overview
        • 20.3.8.5.1. Marketing Strategy
        • 20.3.8.5.2. Product Strategy
        • 20.3.8.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.